22 February 2021 - interim results
Although 2020 was a most challenging year, the specialist veterinary products group has reported a strong first half in its financial year to 30 June 2021. In the six months to 31 December, group revenue rose by 20.6% to £299.8m, with underlying pre-tax profits increasing by 32.2% to £75.1m. Underlying earnings per share were 25.2% higher at 54.6p and the interim dividend was raised by 8% to 11.11p. Net debt increased to £204.0m from £127.6m at 30 June due to the funding of the Osurnia . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
